Method for manufacturing yarn for vessel stent
A stent for a vessel implanted in the vessel of the living body including a main body portion of the stent formed into a tube by a yarn formed of a biodegradable polymer exhibiting a shape memory function. The main body portion of the stent is shape-memorized to a size that can be inplanted in the vessel. The main body portion of the stent is implanted in the vessel of the living body as it is contracted in diameter by an external force, and is enlarged in diameter by being heated with the temperature of the living body. The main body portion of the stent is formed by winding a yarn formed of a biodegradable polymer in a tube form as the yarn is bent in a zigzag design. The main body portion of the stent is enlarged or contracted in diameter with the bends of the yarn as the displacing portions.
1. A method for manufacturing a yarn for a vessel stent comprising the steps of:
compressing and melting pellets formed of a biodegradable polymer,
heating said pellets to a temperature in the vicinity of its melting point (Tm) or a temperature higher than its melting point and lower than its thermal decomposition point by a screw extruder,
extruding said melted biodegradable polymer from a nozzle of said screw extruder to form a yarn, and
bending said yarn in a zig zag design to constitute a tubular main body portion of said vessel stent to obtain said yarn for the vessel stent,
said nozzle being controlled to have a temperature not higher than the melting point and not lower than the glass transition temperature of the biodegradable polymer.
2. A method for manufacturing a yarn for a vessel stent according to claim 1 wherein said nozzle is controlled to have the temperature higher than the glass transition temperature (Tg) of said biodegradable polymer.
3. A method for manufacturing a yarn for a vessel stent according to claim 1 wherein said pellets formed of the biodegradable polymer are heated at a temperature lower than its melting point (Tm) under drying in vacuum and then charged into the screw extruder.
4. A method for manufacturing a yarn for a vessel stent according to claim 1 wherein said yarn extruded from the screw extruder is drawn further.
5. A method for manufacturing a yarn for a vessel stent according to claim 1 wherein said yarn extruded from the screw extruder is formed into a non-interrupted continuous monofilament.
6. A method for manufacturing a yarn for a vessel stent according to claim 1 wherein said biodegradable polymer has the glass transition temperature (Tg) lower than approximately 70° C.
7. A method for manufacturing a yarn for a vessel stent according to claim 1 wherein said biodegradable polymers are one or more from among polylactic acid (PLLA), polyglycolic acid (PGA), a copolymer of polyglycolic acid and polylactic acid, polydioxanone, a copolymer of trimethylene carbonate and glycollide, and a copolymer of polyglycolic acid or polylactic acid and ε-caprolactone.
8. A method for manufacturing a yarn for a vessel stent according to claim 1 wherein said biodegradable polymer matrix contains one or more of an X-ray non-transmitting agent, an anti-thrombotic agent, pharmaceuticals for suppressing neointima hyperplasia, a β-ray radiation source and a γ-ray radiation source.
9. A method for manufacturing a yarn for a vessel stent according to claim 1 further comprising a step of depositing one or more of an X-ray non-transmitting agent, an anti-thrombotic agent, pharmaceuticals for suppressing neointima hyperplasia, a β-ray radiation source and a γ-ray radiation source on the surface of said yarn.
10. A method for manufacturing a yarn for a vessel stent comprising the steps of:
(A) obtaining a yarn made by the following process:
( 1 ) compressing and melting pellets formed of a biodegradable polymer,
( 2 ) heating said pellets to a temperature in the vicinity of its melting point (Tm) or a temperature higher than its melting point and lower than its thermal decomposition point by a screw extruder, and
( 3 ) extruding said melted biodegradable polymer from a nozzle of said screw extruder to form said yarn, and
(B) bending said yarn in a zig zag design to constitute a tubular main body portion of
said vessel stent to obtain said yarn for a vessel stent, said nozzle being controlled to have a temperature not higher than the melting point and not lower than the glass transition temperature of the biodegradable polymer.
11. A method for manufacturing a yarn for a vessel stent according to claim 10 wherein said nozzle is controlled to have the temperature higher than the glass transition temperature (Tg) of said biodegradable polymer.
12. A method for manufacturing a yarn for a vessel stent according to claim 10 wherein said pellets formed of the biodegradable polymer are heated at a temperature lower than its melting point (Tm) under drying in vacuum and then charged into the screw extruder.
13. A method for manufacturing a yarn for a vessel stent according to claim 10 wherein said yarn extruded from the screw extruder is drawn further.
14. A method for manufacturing a yarn for a vessel stent according to claim 10 wherein said yarn extruded from the screw extruder is formed into a non-interrupted continuous monofilament.
15. A method for manufacturing a yarn for a vessel stent according to claim 10 wherein said biodegradable polymer has the glass transition temperature (Tg) lower than approximately 70° C.
16. A method for manufacturing a yarn for a vessel stent according to claim 10 wherein said biodegradable polymers are one or more from among polylactic acid (PLLA), polyglycolic acid (PGA), a copolymer of polyglycolic acid and polylactic acid, polydioxanone, a copolymer of trimethylene carbonate and glycollide, and a copolymer of polyglycolic acid or polylactic acid and ε-caprolactone.
17. A method for manufacturing a yarn for a vessel stent according to claim 10 wherein said biodegradable polymer matrix contains one or more of an X-ray non-transmitting agent, an anti-thrombotic agent, pharmaceuticals for suppressing neointima hyperplasia, a β-ray radiation source and a γ-ray radiation source.
18. A method for manufacturing a yarn for a vessel stent according to claim 10 further comprising a step of depositing one or more of an X-ray non-transmitting agent, an anti-thrombotic agent, pharmaceuticals for suppressing neointima hyperplasia, a β-ray radiation source and a γ-ray radiation source on the surface of said yarn.